Detection of MYD88 Mutations in Vitreoretinal Lymphoma and Its Implications

Valerie Touitou^{1

2}, Myrto Costopoulos^{2

3

4}, Karim Maloum³

Affiliations

¹ Department of Ophthalmology, Pitie Salpetriere Hospital, Paris, France.
² Sorbonne Universities, Paris, France.
³ Department of Biological Haematology, Pitie Salpetriere Hospital, Paris, France.
⁴ INSERM U1138, Programmed Cell Death and Physiopathology of Tumor Cells, Team 19, Centre de Recherche des Cordeliers, Paris, France.

Comment

Valerie Touitou et al. JAMA Ophthalmol. 2018.

. 2018 Oct 1;136(10):1104-1105.

doi: 10.1001/jamaophthalmol.2018.2894.

Valerie Touitou^{1

2}, Myrto Costopoulos^{2

3

4}, Karim Maloum³

¹ Department of Ophthalmology, Pitie Salpetriere Hospital, Paris, France.
² Sorbonne Universities, Paris, France.
³ Department of Biological Haematology, Pitie Salpetriere Hospital, Paris, France.
⁴ INSERM U1138, Programmed Cell Death and Physiopathology of Tumor Cells, Team 19, Centre de Recherche des Cordeliers, Paris, France.

No abstract available

Comment on

Potential Diagnosis of Vitreoretinal Lymphoma by Detection of MYD88 Mutation in Aqueous Humor With Ultrasensitive Droplet Digital Polymerase Chain Reaction.
Hiemcke-Jiwa LS, Ten Dam-van Loon NH, Leguit RJ, Nierkens S, Ossewaarde-van Norel J, de Boer JH, Roholl FF, de Weger RA, Huibers MMH, de Groot-Mijnes JDF, Kuiper JJW. Hiemcke-Jiwa LS, et al. JAMA Ophthalmol. 2018 Oct 1;136(10):1098-1104. doi: 10.1001/jamaophthalmol.2018.2887. JAMA Ophthalmol. 2018. PMID: 30027272 Free PMC article.